UK approval of COVID vaccine is a giant hooray for science

As the first vaccine out of trial is administered, Anjana Ahuja reflects on the significance. After the UK's medicines regulator granted the Pfizer & BioNTech's mRNA vaccine approval for use in the country, science commentator Anjana Ahuja takes a moment in the Financial Times to contextualise the vast significance of the moment. At the same time, she explains why even though it's an important moment for science and the world, caution and social distancing are still our biggest assets against the pandemic.